Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

A dog in Germany was successfully treated for a rare bacterial infection without spreading it to humans.

Prurigo nodularis is hard to diagnose and treat, but new biologics offer hope for better management.

Chikungunya can cause hyperpigmentation in children and should be considered in diagnosis.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Many patients in the rheumatology clinic adjusted or stopped their medications due to side effects.

Abrocitinib may effectively treat Lichen Planopilaris.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Tofacitinib may help treat hair loss in children with alopecia areata.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Dupilumab for eczema may cause hair loss.

Apremilast did not work for treating severe alopecia areata.

Switching to a twice-weekly betamethasone treatment led to full hair regrowth in alopecia areata without side effects.

Semaglutide may worsen eating disorders in vulnerable individuals.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Entospletinib effectively prevents eye and skin GVHD in mice.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Ulcerative sarcoidosis in body folds is rare and improved with prednisone and hydroxychloroquine.